Danger signalling during cancer cell death: origins, plasticity and regulation

por Garg, A D, Martin, S, Golab, J, Agostinis, P
Publicado 2014

Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins

por Dwojak, M, Bobrowicz, M, Bil, J, Bojarczuk, K, Pyrzynska, B, Siernicka, M, Malenda, A, Lech-Maranda, E, Tomczak, W, Giannopoulos, K, Golab, J, Winiarska, M
Publicado en Blood Cancer J (2015)

GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy

por Firczuk, M, Gabrysiak, M, Barankiewicz, J, Domagala, A, Nowis, D, Kujawa, M, Jankowska-Steifer, E, Wachowska, M, Glodkowska-Mrowka, E, Korsak, B, Winiarska, M, Golab, J
Publicado 2013

Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF

por Golab, J, Wilczynski, G, Zagozdzon, R, Stoklosa, T, Dabrowska, A, Rybczynska, J, Wasik, M, Machaj, E, Oldak, T, Kozar, K, Kaminski, R, Giermasz, A, Czajka, A, Lasek, W, Feleszko, W, Jakobisiak, M
Publicado 2000

Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity

por Nowis, D, Legat, M, Grzela, T, Niderla, J, Wilczek, E, Wilczyñski, GM, Głodkowska, E, Mrówka, P, Issat, T, Dulak, J, Józkowicz, A, Waś, H, Adamek, M, Wrzosek, A, Nazarewski, S, Makowski, M, Stokłosa, T, Jakóbisiak, M, Gołąb, J
Publicado 2006